All News #Library
Biotech
NovalGen Initiates First Self-Regulating Immunotherapy Trial
17 Sep 2025 //
GLOBENEWSWIRE
Mabion, NovalGen Partner to Bring NVG-222 to Market
30 Jun 2025 //
CONTRACTPHARMA

Market Place
Sourcing Support